progress

Canadian PM Carney announces progress in Canada-US trade deal talks ahead of US midterm elections on November 3.

Canadian Prime Minister Mark Carney has announced progress towards a future trade deal with the United States, which could help ease tensions between the two North American neighbours.

The Sunday announcement came just two days before the November 3 US midterm elections, which will determine control of the US Congress.

“Good conversation with US President Donald Trump on the future of Canada-U.S. trade,” Carney posted on X on Sunday.

Ties between Ottawa and Washington have been strained by an escalating trade war, with Canada and the US imposing billions of dollars in tariffs on each other’s goods in recent months.

“Teams from both countries will be working in the coming weeks to deliver that outcome,” Carney said. “This builds on recent constructive discussions on the outlines of a mutually beneficial trade deal.”

In his second term, Trump has upended global trade by imposing tariffs on many of the US’s allies, including Canada – one of the US’s biggest trading partners.

In August, high-level trade talks between Ottawa and Washington broke down, and Trump imposed a 50 percent levy on $20bn of Canadian goods, or 5.5 percent of its exports. Canada responded with equivalent tariffs on US steel, dairy, appliances, farm equipment, pulp and paper, and electronics.

Trump said last week that he expected a new trade agreement with Canada to be reached “pretty soon”, but offered no details.

The trade tensions with Canada have become an issue in the midterm elections, particularly in Michigan and Maine, where Republican candidates have faced pressure over tariffs that have hurt local businesses.

Canada has sought to diversify its trade options and recently welcomed a European Union offer to become an “associate member”.

Carney praised the proposal’s ambition, describing his goal as a “unique alliance” rather than conventional EU membership.

Airbus U.S. Space and Defense has been actively developing and iterating the technology for its Lakota Connector, an uncrewed, autonomous variant of the multi-mission UH-72B Lakota helicopter. This includes testing under Team Lakota Connector, that has brought together Shield AI, L3Harris Technologies, and Parry Labs in a prototyping phase for the U.S. Marine Corps.

TWZ’s Jamie Hunter spoke with Carl Forsling from Airbus U.S., at the AUSA 2026 trade event in Washington D.C. A former U.S. Marine Corps CH-46 Sea Knight and MV-22 Osprey pilot, Forsling explained the requirement for uncrewed logistics in contested theaters, and what’s next for Team Lakota Connector.

Airbus Talks Progress With Lakota Connector Cargo Drone

Maria Astorini, a retired character actress and a minor star, is 37 years late delivering her memoir. But the project, which she has tried her best to forget, has been pulled out from under the rug by her publisher. Forced to deliver a manuscript, Maria writes an autobiography clocking in at a shade over 200 pages.

The result is Elizabeth Castellano’s second novel “Proof of Progress,” a wry, poignant and very funny twirl through a life that swerves past triumph and failure, boredom and joy, public life and private sorrow. I recently spoke with her about Bloomingdale’s, Calvin Trillin, and how cellphones are the enemy of good fiction.

✍️ Author Chat

”Proof of Progress” traces the life of your protagonist, Maria Astorini, from childhood to her mid-60s. It reminded me of something Bob Dylan wrote recently about growing older, which is that you finally get rid of the illusion that life is under your control.

For Maria, there is a lot of serendipity that feels like fate, of being in the right place at the right moment, or meeting the right person, which sends her off in a different direction. I like that in a novel. It was also helpful to be writing primarily about an era without phones, so that she’s able to meet a lot of people.

We’re seeing this a lot in contemporary narratives: writers setting their stories in pre-phone eras, so their characters can actually interact with each other.

She’s talking to people, she’s meeting people, so she’s able to be sent on different paths. Even meeting her husband probably wouldn’t have happened with the phone.

“Proof of Progress” is Elizabeth Castellano’s second novel.

(Harper Collins / Carl Timpone)

You have written a very funny book, and funny books don’t get the respect they deserve.

Anytime you have humor in a book, you’re not taken quite as seriously. Even in Barnes & Noble, when you look for humor, it’s on the back wall or on the floor. And that’s where you find the David Sedaris books, which is crazy. My last book was about a beach town, so I got lumped in with the beach read group. I had people who were looking for a fun beach read and then they picked up my book, and it’s about zoning code violations. I’m happy that this book is being marketed as literary and humorous. I’m in better shape in that sense.

It’s really hard to write funny. Or is it?

The best way I can describe it is like a stand-up comedian having a notebook full of jokes and anecdotes and she has to put together an HBO special. Sometimes I just had one line of something funny. I had all these ideas and thoughts and different things from old books that I was writing. I tried to put all of it together and find a character that could tell this story, and the through line that I could create from all of this material. So I wrote it backwards and out of order.

Who do you think is funny? Who do you like to read?

J.D. Salinger, David Sedaris, Maria Semple. I love Calvin Trillin. I think he’s a great writer.

Your protagonist is very late on a contract and has to rush to get the book written, which gives the narrative propulsion and momentum.

I had a two-book deal, so while I was working on the publicity for my first book, I raced to finish this book. And when I was finished, I realized it didn’t work and had to throw out the whole manuscript. I saved maybe six or seven little anecdotes from that original book. So it took another year to write. That was the inspiration for “Proof of Progress.”

Your writing career is a bit like Maria’s acting career, in that you chanced upon it.

I was a theater major. I don’t think I took one English course. Then I graduated right into the Recession of 2008. There were no jobs. Eventually, I applied to be an apprentice buyer at Bloomingdale’s, even though I hate shopping. That was the last resort. Then I decided, maybe I’ll be a writer, because it felt like something that I could do. I wrote a lot of things that were rejected before I wrote my first book, “Save What’s Left” [2023]. And that’s probably why I wrote Maria the way I did. We zig, we zag, we endure.

This Q&A was edited for length and clarity.

📰 The Week(s) in Books

Kyle MacLachlan’s new memoir is a funny, candid and self-aware reflection on his 40-year career in Hollywood.

(Christopher Patey / For The Times)

We loved him as Special Agent Cooper in “Twin Peaks” and as Jeffrey Beaumont in “Blue Velvet,” but according to Kyle Maclachlan’s new memoir, “Fictional Selves,” there is another unknown character: “Other Kyle,” the actor’s ever-present shadow figure. “There’s definitely another entity, an observer, the ego, the harder self,” MacLachlan tells Rachel Brodksy.

After a nine-year absence from fiction, John Green has returned with “Hollywood, Ending,” a darkly humorous show business cautionary tale that Green couldn’t have written “without spending a lot of time on film sets,” he tells Emily St. Martin. “I hope the book is a love letter to movies. But I also wanted to be honest about how difficult it is to make a work of art that, in order to be commercially successful, has to be loved by millions of people.”

Katya Suvorova’s memoir, “Ungrateful Immigrant Daughter,” is a “heart-wrenching tale of immigration” that “pulls back the velvety red curtain to reveal one story behind the oversexualized stereotypical post-Soviet mail-order bride narrative so ingrained in post-Cold War U.S. culture,” writes Diana Ruzova.

Finally, Vroman’s and Book Soup, two of L.A.’s most beloved bookstores, have been sold by longtime owner Joel Sheldon to tech executive Robert Hoffman, reports Suhauna Hussain.

📖 Bookstore Faves

Outpost Books is a new bookstore in South Pasadena.

(Simran Malik)

Walking into Outpost Books is like stepping into a smart book lover’s cozy den. With its southwestern-themed design and a well-curated selection of new and used books, the indie book store in South Pasadena already feels like home to this community of rabid book lovers. I spoke with owner Nicole Novembrino about her new store.

Why a bookstore?

I was a sales rep for a publisher of art books, but I looked at my life, wondering what I could do for a living that would give me real meaning and purpose. I love books, and so I decided to open a bookstore. It’s not easy, and you can second-guess yourself a million times along the way, or get a normal job. But I’m so glad I did it. Everyone in the neighborhood is so happy!

Why did you choose to open in South Pasadena?

I live in El Sereno nearby, and South Pasadena is such a great community. When we first opened, people were coming in and thanking us for opening in the neighborhood. There aren’t any other bookstores in this particular South Pasadena neighborhood. I definitely didn’t want to take any business away from other stores.

Pasadena loves its bookstores.

This is a very bookish community. The donations I’m getting from people are really smart volumes. I think I’ve had just one Nora Roberts book! The landlords are great, as well. They came to our opening and told me the store is all they could have dreamed of for the space, which is so sweet.

The kids section is really fun, with the tent and the fake tree stumps.

We have a lot of kids books with a southwestern theme. I’ve been collecting them over the years from my trips to the desert. You might find a book called “Armadillo Rodeo” in there.

How did you land on the western theme?

My mom is from New Mexico, so every family vacation was a trip to the Southwest, and I loved stopping and collecting things at the trading posts along the way. I wanted to give the store that kind of feel. I chose the name Outpost for that reason. It is a lived-in place where you can just hang out and find cool things and read.

Outpost Books, 1010 ½ Fair Oaks Ave., South Pasadena, (626) 399-0595

Oct. 3, 2026 3:03 AM PT

Menopause has been having a moment lately, and Washington is taking notice. On Sept. 16, the Senate held its first hearing on the dismal state of federally funded menopause research and vast gaps in treatment and care. Within 24 hours, the Department of Health and Human Services also convened pharmaceutical manufacturers and physicians to troubleshoot the alarming lack of availability of estradiol patches, an essential menopause hormone treatment, and the Food and Drug Administration held a full day of expert panels on female-dosed testosterone, which is currently only FDA-approved for men.

One week later, Health and Human Services joined the American Urological Assn. for a discussion about a silent killer of postmenopausal women: urosepsis from recurrent urinary tract infections. There is a simple solution — localized vaginal estrogen — and yet because of outdated guidelines and lack of clinician training, the medication is too often ignored or denied. Nor is the prescription routinely covered by Medicare, despite its well-established health and longevity benefits for women over age 65.

These are among the attempts to now, finally, address decades of policy failures — a refreshing change, quite frankly, given neither political party has ever prioritized menopause. That 2026 marks the year when menopause has entered the policy arena comes as little surprise to me. I’ve been beating this drum for years. Every aspect of daily life that menopause touches — the soaring cost of medical care, inadequate access to health insurance, extreme underinvestment in scientific research focused on women’s health, even the myriad ways midlife women are stretched to the limit caring for kids and aging parents — is smack in the middle of the political zeitgeist. These are the kitchen table issues on the minds of voters this election.

Menopause moment, meet the midterms.

Another issue rightly revealed by menopause is the chasm of public trust in government. As one of the four expert witnesses who testified at the Senate, I was heartened that it was a true bipartisan endeavor. But that’s a rarity these days in Congress, an institution rife with dysfunction. Our federal health agencies have become so shamelessly politicized they are on a collision course with science — from HHS’ overt moves to undermine childhood vaccines, to the decimation of leadership at the Centers for Disease Control and Prevention, which is struggling to respond to the crisis of measles outbreaks across the country.

My goal as a policy advocate is to help turn the tide on this country’s long record of neglect when it comes to menopause. Like many other women’s and reproductive health advocates, after the 2024 election l turned my attention to state legislatures — not just as a consolation prize but as a way to test what range of reforms were feasible and to get as many good laws as possible passed. It was the right move. Over the last two years, more than 60 bills have been introduced in 28 states — to do things like require private insurance and Medicaid to cover menopause care and treatment, improve clinician training and public education, and bolster antidiscrimination protection in the workplace. Ten of those states now have 21 laws on the books.

California is one and can claim real leadership. Among the bills passed by the Legislature, Assembly Bill 2270 from 2023-24 incentivizes continuing medical education on menopause for clinicians, the majority of whom receive little to zero training while in medical school and residency. The California Department of Corrections is now collaborating with medical experts to help bring menopause resources to incarcerated women in state prisons.

Newsom also just vetoed AB 1940, which would have codified menopause as a protected category in the state’s workplace antidiscrimination laws.

The Legislature has been especially deft at easing access to FDA-approved hormonal treatments, including testosterone, often used off-label by menopausal women: AB 82 ends the requirement to report prescriptions to the state’s tracking database; AB 1778 proactively declassifies testosterone as a controlled substance under state law, should there be action in Washington to do the same under federal law.

Although Newsom twice vetoed bills to mandate insurance coverage for menopause treatment — and deserved all the flak he received — the 2026-27 state budget includes a minor course correct: a $3.4-million “trailer bill” to invest in public education and make menopause treatments more affordable; Medi-Cal patients are not fully covered by the addendum, though, making it a toothless reform for those who need support the most.

Why should California’s menopause agenda, or that of the other 27 states that have introduced reforms, matter to the rest of the country? They offer useful models of what to do — or in the case of Medicaid exclusion, what not to do — in crafting meaningful policies. Perhaps more important, they offer a rationale that can help persuade the public; those who might balk at a congressional bill or federal policy, in part because of skepticism of the federal government or the current administration, can listen to and learn from other stakeholders, including governors and state lawmakers and activists.

Take for example the FDA decision in November 2025 to remove the long-critiqued “black box” warning on estrogen products for menopause. This was the culmination of a decade-long campaign by physicians, researchers and scientists — who had been waging the fight for accurate labeling well before the acronym MAHA ever existed and regardless of which party held power. Yet the very image of Health Secretary Robert F. Kennedy Jr. using his moment at the podium to credit the Trump administration’s deep commitment to women’s health posed a serious credibility challenge. Aligned and contemporaneous state reforms offered much-needed reassurance and clarity to many.

Trust in government is understandably at a low point, but this happens to be when menopause finally has caught the attention of policymakers at all levels of power. Some are taking long-overdue steps for women’s health, however implausibly. Let’s take the wins.

Jennifer Weiss-Wolf is the author of “When in Menopause: A User’s Manual & Citizen’s Guide.” She is executive director of NYU Law’s Birnbaum Women’s Leadership Center.